These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical manifestations of primary aldosteronism. Rovner DR Am J Clin Pathol; 1970 Sep; 54(3):314-5. PubMed ID: 4319207 [No Abstract] [Full Text] [Related]
26. Endocrine causes of hypertension. Batsakis JG J Ky Med Assoc; 1973 Mar; 71(3):159-68 passim. PubMed ID: 4348559 [No Abstract] [Full Text] [Related]
27. [Renin-angiotensin-(aldosterone)-system-clinical aspects]. Börner H Z Gesamte Inn Med; 1973 Dec; 28(24):757-62. PubMed ID: 4360460 [No Abstract] [Full Text] [Related]
29. [Molecular structure of renin-angiotensin-aldosterone system]. Zelechowski M; Pokrzywnicki W Pol Merkur Lekarski; 1999 Apr; 6(34):202-4. PubMed ID: 10391061 [TBL] [Abstract][Full Text] [Related]
30. Aldosterone and other mineralocorticoids in Bartter's syndrome. Saruta T; Fujimaki M; Senba S; Saito I; Konishi K J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989 [TBL] [Abstract][Full Text] [Related]
31. [Behavior of the renin-angiotensin-aldosterone system and of electrolyte and water excretion in male and female spontaneously hypertensive and normotensive rats under the influence of a saluretic]. Erbler HC Z Versuchstierkd; 1979; 21(2):112-21. PubMed ID: 442846 [No Abstract] [Full Text] [Related]
33. Commentary on incidence of primary aldosteronism: current estimations based on objective data. Kaplan NM Arch Intern Med; 1969 Feb; 123(2):152-4. PubMed ID: 4884278 [No Abstract] [Full Text] [Related]
34. Recent developments in pathophysiologic studies of the renin-angiotensin system. Haber E N Engl J Med; 1969 Jan; 280(3):148-55. PubMed ID: 4302194 [No Abstract] [Full Text] [Related]
35. [New data on hormone-dependent hypertension and their significance for the practice]. Horký K; Petrásek J; Marek J Cas Lek Cesk; 1973 Jan; 112(1):3-11. PubMed ID: 4345613 [TBL] [Abstract][Full Text] [Related]
36. [Relationship between sweat, sodium and potassium excretion and the renin-angiotensin-aldosterone system in hypertension]. Rosset G Schweiz Med Wochenschr; 1973 Mar; 103(12):439-48. PubMed ID: 4697590 [No Abstract] [Full Text] [Related]
37. [Activation of the adrenal cortex by the kidney. The renin-angiotensin-aldosterone system]. Labadie P Rev Prat; 1965 May; 15(15):2072-81. PubMed ID: 4284447 [No Abstract] [Full Text] [Related]
38. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication. Vetter H; Vetter W Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313 [TBL] [Abstract][Full Text] [Related]
39. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]. Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287 [TBL] [Abstract][Full Text] [Related]
40. Aldosterone metabolites and possible aldosterone precursors in hypertension. Vecsei P; Abdelhamid S; Mittelstädt GV; Lichtwald K; Haack D; Lewicka S J Steroid Biochem; 1983 Jul; 19(1A):345-51. PubMed ID: 6887870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]